Clinical Trials Browser

Phase 1/2 × AZD4547 × Clear all

NCT01824901 2023-06-29

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

Phase 1/2 Completed

2 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT01791985 2022-08-22

RADICAL

Phase 1/2 Completed

52 enrolled 17 charts

Breast Neoplasms

NCT05086666 2021-10-21

A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547

Phase 1/2 Unknown

Carcinoma, Transitional Cell

NCT01202591 2016-02-11

GLOW

Phase 1/2 Completed

127 enrolled 8 charts

Breast Neoplasms